IndiaFilingsIndiaFilings
India FlagRegister India Company
UAE FlagRegister UAE Company
USA FlagRegister USA Company

NIMBASIA PHARMACEUTICALS AND SPECIALITIES LLP

LLPIN : AAW-1409|ROC: RoC-JaipurActive
Last Updated On : 12-03-2022
LLPINAAW-1409
LLP NameNIMBASIA PHARMACEUTICALS AND SPECIALITIES LLP
Number of Partners4
Number of Designated Partners4
ROC CodeRoC-Jaipur
Date of Incorporation03-03-2021
Registered AddressCO NIMBASIA STABILIZERS,PLOT NO F-172 (A AND B) F -173 ,INDRAPRASTHA INDUSTRIAL AREA, RO AD NO 3 KOTA Kota RJ 324005 IN
Email ID[email protected]
Total Obligation of Contribution10,00,000
Main division of business activity to be carried out in India24
Description of main divisionManufacture of chemicals and chemical products
Date of last financial year end for Annual Return filed31-03-2021
LLP StatusActive

Directors / Signatory Details

DIN / PANNameBegin Date
02475167PRAMOD KUMAR AGARWAL03-03-2021
08640742SHARUN MITTAL03-03-2021
08640741RAVISHU MITTAL03-03-2021
08649499SAUMYA MITTAL03-03-2021
NIMBASIA PHARMACEUTICALS AND SPECIALITIES LLP is a Limited Liability Partnership (LLP) governed by the LLP Act, 2008. Registered under the Registrar of Companies RoC-Jaipur, it operates as a non-government entity. According to the Ministry of Corporate Affairs (MCA), this LLP was incorporated on 03-03-2021 and last updated on 12-03-2022. Its LLP Identification Number (LLPIN) is , and the registration number is . Currently, its eFiling status is listed as “Active” as per MCA records.
From a financial standpoint, NIMBASIA PHARMACEUTICALS AND SPECIALITIES LLP has a total contribution of INR 10,00,000. Details of the latest financial filings, such as the Statement of Accounts and Solvency or Annual Returns, are unavailable, indicating limited publicly disclosed financial data.
The registered office address is CO NIMBASIA STABILIZERS,PLOT NO F-172 (A AND B) F -173 ,INDRAPRASTHA INDUSTRIAL AREA, RO AD NO 3 KOTA Kota RJ 324005 IN. Correspondence or inquiries may be sent to the official email address, [email protected].
For those interested in further details, below are some frequently asked questions: